BusinessAlphatec Spine Launches Battalion™ Lateral System with Squadron™ Retractor to support Minimally Invasive Lateral Access ProceduresBy Nasdaq OMXApr 7, 2017, 12:35 PM UTC
BusinessMyriad Genetics and BeiGene Sign Agreement to Develop Companion Diagnostics for Use with BeiGene’s Novel PARP Inhibitor, BGB-290By Nasdaq OMXApr 6, 2017, 11:05 AM UTC
BusinessPivotal Study Results for Myriad’s myPath® Melanoma Test Highlighted In Two Additional Scientific PublicationsBy Nasdaq OMXApr 5, 2017, 11:05 AM UTC
BusinessInterim Phase 2 Data Demonstrate Robust Response Rate with Indoximod in Combination with Keytruda® (pembrolizumab) for Patients with Advanced Melanoma at AACR PlenaryBy Nasdaq OMXApr 4, 2017, 12:30 PM UTC
BusinessAdvantis Corporation CEO, Chris Swartz, Discusses Current Events and Recent News in a New Interview at SmallCapVoice.comBy Nasdaq OMXMar 31, 2017, 6:27 PM UTC
BusinessBioSig Technologies Announces Participation in Lafayette College’s InternShift Summer ProgramBy Nasdaq OMXMar 30, 2017, 12:01 PM UTC
BusinessFibrocell Regains Compliance with NASDAQ Listing RequirementsBy Nasdaq OMXMar 28, 2017, 12:01 PM UTC
